Showing results (121-130 of 596) with videos related to
Sort By:
Pageof 60
Diabetes|November 18, 2020
Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD MiceFernanda M C Sodré, Samal Bissenova, Ylke Bruggeman, et al.European Journal of Immunology|July 24, 2013
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation eventsElio Schouppe, Camille Mommer, Kiavash Movahedi, et al.Molecular Imaging and Biology|January 21, 2022
Fluorine MR Imaging Probes Dynamic Migratory Profiles of Perfluorocarbon-Loaded Dendritic Cells After Streptozotocin-Induced InflammationShweta Saini, An-Sofie Vanherwegen, Sayuan Liang, et al.Expert Review of Proteomics|June 27, 2017
Understanding type 1 diabetes through proteomicsInne Crèvecoeur, Saurabh Vig, Chantal Mathieu, et al.Kidney International|February 26, 2010
Vitamin D: a pleiotropic hormoneAnnemieke Verstuyf, Geert Carmeliet, Roger Bouillon, et al.Expert Opinion on Medical Diagnostics|March 19, 2013
Proteomics as a tool to discover biomarkers for the prediction of diabetic complicationsMichael Maris, Lut Overbergh, Wannes D'Hertog, et al.Diabetes Care|April 20, 2026
The Importance of C-Peptide for Developing T1D Disease-Modifying TherapiesG Alexander Fleming, Chantal Mathieu, Jay S SkylerProteomics. Clinical Applications|February 3, 2015
The beta-cell in type 1 diabetes: What have we learned from proteomic studies?Inne Crèvecoeur, Dieter Rondas, Chantal Mathieu, et al.Endocrine-Related Cancer|June 14, 2012
GLP1 and cancer: friend or foe?Roman Vangoitsenhoven, Chantal Mathieu, Bart Van der SchuerenDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 6, 2019
Empagliflozin in type 1 diabetesChantal Mathieu, Laura Van Den Mooter, Bert EeckhoutPageof 60